C12N 2523/00
Culture process characterised by temperature
C12N2523/00 (Culture process characterised by temperature) appears on 157 US grants and 352 published applications in this corpus.
Search patents in C12N- Granted patents
- 157
- Published applications
- 352
- Assignees
- 258
- Inventors
- 893
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 1 | 3 |
| 2010 | 0 | 2 |
| 2011 | 0 | 5 |
| 2012 | 1 | 3 |
| 2013 | 4 | 5 |
| 2014 | 3 | 4 |
| 2015 | 1 | 13 |
| 2016 | 2 | 12 |
| 2017 | 9 | 11 |
| 2018 | 2 | 27 |
| 2019 | 4 | 21 |
| 2020 | 11 | 26 |
| 2021 | 18 | 46 |
| 2022 | 15 | 53 |
| 2023 | 21 | 36 |
| 2024 | 29 | 42 |
| 2025 | 24 | 27 |
| 2026 | 11 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cell therapeutic agent for cancer treatment and combination therapy with same15 Sep 2026US 12,735,680 B2Cell & Brain Co., Ltd
- Methods of preserving mesenchymal stem cells16 Jun 2026US 12,653,841 B2Children's Healthcare of Atlanta, Inc.
- Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy2 Jun 2026US 12,642,268 B2Iovance Biotherapeutics, Inc.
- Nucleic acids, vectors, host cells and methods for production of fructosyltransferase from Aspergillus japonicus21 Apr 2026US 12,606,806 B2Revelations Biotech Pvt Ltd
- Injectable off-the-shelf cartilage, tendon, and ligament repair compositions and methods of use7 Apr 2026US 12,595,463 B2Epibone, Inc.
- Injectable off-the- shelf cartilage, tendon, and ligament repair compositions and methods of use13 Aug 2026US 2026/0234550 A1Epibone, Inc.
- Methods of human retinal progenitor cell isolation and culture16 Jul 2026US 2026/0201322 A1The Regents of the University of California
- Macrophage-modification technique for treating metastatic solid tumors25 Jun 2026US 2026/0176584 A1The Florida State University Research Foundation, Inc.
- Mesenchymal lineage precursor or stem cells with enhanced immunosuppression14 May 2026US 2026/0132378 A1Mesoblast International Sarl
- Expansion of tumor infiltrating lymphocytes from liquid tumors and therapeutic uses thereof7 May 2026US 2026/0124242 A1Iovance Biotherapeutics, Inc.
Most cited
By later US patents
- Method for animal cell culture187US 5,976,833 ASuntory Limited · 1999
- Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy14US 9,884,076 B2Capricor, Inc. · 2018
- Progenitor cells from wharton's jelly of human umbilical cord12US 7,547,546 B2Tissue Regeneration Therapeutics Inc. · 2009
- Warmer and process for promoting a biological reaction12US 9,926,530 B2Laboratories Genevrier · 2018
- Methods and compositions for increasing nuclease activity11US 8,772,008 B2Sangamo BioSciences, Inc. · 2014